当前位置: X-MOL首页全球导师 国内导师 › 付彩云

个人简介

1. 1999.09-2003.06 兰州大学生命科学学院生物学基地班,学士 (班主任:张迎梅教授) 2. 2003.09-2008.06 兰州大学生命科学学院生物化学与分子生物学研究所,硕博连读,理学博士(导师:王锐教授) 3. 2008.12-至今 浙江理工大学,生命科学学院讲师,副教授(2019.04 特聘教授) 4. 2013.10-2014.01 墨尔本Peter MacCallum Cancer Centre访问学者

研究领域

1. 小分子靶向药研发与肿瘤靶向治疗 2. 多肽药理学

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

1. Lu Y, Zhang TF, Shi Y, Zhou HW, Chen Q, Wei BY, Wang X, Yang TX, Chinn YE, Kang J, Fu CY*. PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells. Scientific Reports. 2016, 6: 20823. (corresponding author) 2. Zou Y, Guo CG, Yang ZG, Sun JH, Zhang MM*, Fu CY*. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model for hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery. Drug Design, Development and Terapy, 2016, 10: 1243-1255. (corresponding author) 3. Fang WJ*, Fu CY*, Chen XG, Mou XZ, Liu FL, Qian H, Zhao P, Zheng YL, Zheng Y, Deng J, Ye PJ, Wang YF, Zheng SS. Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients. Oncology Letters, 2015, 9: 2003-2006. (co-first anthor) 4. Zhu XC, Zhang JL, Ge CT, Yu YY, Wang P, Yuan TF*, Fu CY*. Advances in cancer pain from bone metastasis. Drug Design, Development and Terapy, 2015, 9: 4239-4245. (corresponding author) 5. Zhu XC, Ge CT, Wang P, Zhang JL, Yu YY, Fu CY*. Analgesic effects of lappaconitine in leukemia bone pain in a mouse model. PeerJ, 2015, 3:e936. (corresponding author) 6. Fu CY*, Xia RL, Zhang TF, Lu Y, Zhang SF, Yu ZQ*, Jin T, Mou XZ*. Hemokinin-1(4-11)-induced analgesia selectively up-regulates δ-opioid receptor expression in mice. PLoS ONE, 2014, 9(2): e90446. (corresponding author) 7. Fu CY1, Chen W1, Jin YT*. The complete mitochondrial genome of Phrynocephalus guinanensis (Reptilia, Squamata, Agamidae). Mitochondrial DNA,2014, 1-2. 8. Xia RL, Lu Y, Zhu LN, Zhang SF, Zhao FK, Fu CY*. Different regulatory pathways are involved in the proliferative inhibition of two types of leukemia cell lines induced by paclitaxel. Oncology Reports, 2013, 30: 1853-1859. (corresponding author) 9. Zhu LN, Fu CY*, Zhang SF, Chen W, Jin YT, Zhao FK. Novel cytotoxic exhibition mode of antimicrobial peptide anoplin in MEL cells, the cell line of murine Friend leukemia virus- induced leukemic cells. Journal of Peptide Science, 2013, 19: 566-574. (corresponding author) 10. Xia RL, Fu CY*, Zhang SF, Jin YT, Zhao FK. Study on the distribution sites and the molecular mechanism of analgesia after intracerebroventricular injection of rat/mouse hemokinin-1 in mice. Peptides, 2013, 43: 113-120. (corresponding author) 11. Fu CY, Zhao YL, Dong L, Chen Q, Ni JM*, Wang R*. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain, Behavior, and Immunity, 2008, 22: 850-860. 12. Fu CY, Kong ZQ, Long Y, Chen Q, Wang R*. Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: Systemic study in anesthetized rats. European Journal of Pharmacology, 2007, 572 175–181. 13. Fu CY, Tang XL, Yang Q, Chen Q, Wang R*. Effects of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on the antinociceptive activity of pethidine administered at the peripheral and supraspinal level. Behavioural Brain Research, 2007, 184: 39–46. 14. Fu CY, Yang Q, Wang KR, Kong ZQ, Chen Q, Wang R*. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level. Behavioural Brain Research, 2006, 170: 293–301. 15. Fu CY, Kong ZQ, Wang KR, Yang Q, Zhai K, Chen Q, Wang R*. Effects and mechanisms of supraspinal administration of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on nociception in mice. Brain Research, 2005, 1056: 51–58. 16. Long Y1, Fu CY1, Tian XZ, Chen J, Han M, Wang R*. Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: Roles of potassium ion and nitric oxide. European Journal of Pharmacology, 2007, 569: 119–125. (co-first anthor) 17. Kong ZQ1, Fu CY1, Chen Q, Wang R*. Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats. European Journal of Pharmacology, 2008, 590: 310–316. (co-first anthor) 18. Chang HN, Liu BY, Qi YK (Qi, Yun-Kun), Zhou Y, Chen YP, Pan KM, Li WW, Zhou XM, Ma WW, Fu CY, Qi YM, Liu L, Gao YF. Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy. Angewandte Chemie-International Edition, 2015, 54: 11760-11764

推荐链接
down
wechat
bug